Gene Therapy Deal-Making Trends, 2012-2017 Featuring Pfizer, Vertex, Biogen, Bamboo Therapeutics & Gilead … – Business Wire (press release)
Gene Therapy Deal-Making Trends, 2012-2017 Featuring Pfizer, Vertex, Biogen, Bamboo Therapeutics & Gilead …Business Wire (press release)A robust deal-making market has enabled gene therapy drug development to be advanced and adequately funded thr… Continue reading
